Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort

Peter J Campbell, Cathy MacLean, Philip A Beer, Georgina Buck, Keith Wheatley, Jean-Jacques Kiladjian, Cecily Forsyth, Claire N Harrison, Anthony R Green

Research output: Contribution to journalArticlepeer-review

124 Citations (Scopus)

Abstract

Essential thrombocythemia, a myeloproliferative neoplasm, is associated with increased platelet count and risk of thrombosis or hemorrhage. Cytoreductive therapy aims to normalize platelet counts despite there being only a minimal association between platelet count and complication rates. Evidence is increasing for a correlation between WBC count and thrombosis, but prospective data are lacking. In the present study, we investigated the relationship between vascular complications and 21 887 longitudinal blood counts in a prospective, multicenter cohort of 776 essential thrombocythemia patients. After correction for confounding variables, no association was seen between blood counts at diagnosis and future complications. However, platelet count outside of the normal range during follow-up was associated with an immediate risk of major hemorrhage (P = .0005) but not thrombosis (P = .7). Elevated WBC count during follow-up was correlated with thrombosis (P = .05) and major hemorrhage (P = .01). These data imply that the aim of cytoreduction in essential thrombocythemia should be to keep the platelet count, and arguably the WBC count, within the normal range. This study is registered at the International Standard Randomized Controlled Trials Number Registry (www.isrctn.org) as number 72251782.

Original languageEnglish
Pages (from-to)1409-11
Number of pages3
JournalBlood
Volume120
Issue number7
DOIs
Publication statusPublished - 16 Aug 2012

Keywords

  • Follow-Up Studies
  • Hemorrhage
  • Humans
  • Platelet Count
  • Prospective Studies
  • Risk Factors
  • Thrombocythemia, Essential
  • Thrombosis
  • Vascular Diseases

Fingerprint

Dive into the research topics of 'Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort'. Together they form a unique fingerprint.

Cite this